Sign inJoin waitlistJoin the waitlist

Adam Lamble

Associate Professor of Pediatrics · University of Washington School of Medicine

Credentials: · · ·

History

University of Washington School of Medicine
Present

Hematology and Medical Oncology
OREGON HEALTH & SCIENCE UNIVERSITY
2014–2017
Internal Medicine
2011–2014
Doctor of Medicine
2007–2011

Research

Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma
New England Journal of Medicine · 2024 · 205 citations
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL
Journal of Clinical Oncology · 2022 · 191 citations
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
Nature Communications · 2021 · 155 citations

Rebecca Gardner
11 papers
Nirali Shah
10 papers
Michael Pulsipher
9 papers
Colleen Annesley
8 papers
Susan Rheingold
8 papers
AK
Alexandra Kovach
7 papers
Deepa Bhojwani
7 papers
Regina Myers
7 papers
Sara Silbert
7 papers
Soheil Meshinchi
7 papers · 3 as a fellow
Constance Yuan
6 papers
Corinne Summers
5 papers

Clinical trials

Flotetuzumab for the Treatment of Pediatric Recurrent or Refractory Acute Myeloid Leukemia
Principal investigator · Active not recruiting · Phase 1
Children's Oncology Group
2020–2027
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Study chair · Recruiting · Phase 1
Therapeutic Advances in Childhood Leukemia Consortium
2022–2027
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Site PI · Recruiting · Phase 2
Allotera Therapeutics
2025–2028
PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML
Site PI · Recruiting · Phase 1
Seattle Children's Hospital
2021–2041